Company: AbbVie Inc. (ABBV)
*DRIP Club Members are able to acquire or list a share of a company on the DRIP Exchange Page.
Company Profile: AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox). -Morningstar.com-
Symbol: ABBV
Recent Price: $186.69
Dividends: $6.20
Yield: 3.32%
Sector: Healthcare
Industry: Drugs Manufacturers
Address & Company Phone #: 1 North Waukegan Road North Chicago IL 60064, 847-932-7900
Transfer Agent: Equiniti Group plc. 877-881-5970
Moody’s Rating: Baa2
Minimum & Maximum Investment: $25 – $250,000/year
Investment Dates: Weekly
Shares to Qualify: 1 Share or $250
Fees: Div.: $0 Cash: $0 Cert: $0 Sells: by Mail, Phone or Internet for $15+15¢/sh.
52 Week High & Low: $182.89, $132.70